Industry4h ago
Anthropic Launches Rare Disease Drug Discovery
Anthropic announced preclinical drug-discovery programs targeting neglected diseases on June 30. The company also unveiled Claude Science, a specialized AI workbench for researchers and drug-makers. This move shifts Anthropic from a model provider to a direct participant in biotech R&D. Practitioners can now integrate these specialized tools into pharmaceutical pipelines.